Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. - Wikidata - wikimedia - TriplyDB

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

http://www.wikidata.org/entity/Q43920215

about

Pediatric Atopic Dermatitis: A Review of the Medical Management Topical tacrolimus for atopic dermatitis Dry eye: an inflammatory ocular disease Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.Eczema.Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.Treatment of pruritic diseases with topical calcineurin inhibitors.Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.The role of topical calcineurin inhibitors in atopic dermatitis.Pimecrolimus -- an anti-inflammatory drug targeting the skin.Problem-based learning: a review of current issues relevant to physiotherapy education.Topical tacrolimus in the management of atopic dermatitis in Japan.Atopic eczema: what's new?The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.Management of itch in atopic dermatitis.Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients.New and emerging trends in the treatment of atopic dermatitis.Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.Update on the management of chronic eczema: new approaches and emerging treatment options Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Topical corticosteroids and hospital length of stay in children with eczema herpeticum.Effect of a new drug releasing system on microencapsulated islet transplantation.Tacrolimus ointment in the management of atopic dermatitis.Topical tacrolimus as treatment of atopic dermatitis.Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies.Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis.[Antipruritic effects of pimecrolimus and tacrolimus].[Long term management of childhood atopic dermatitis with calcineurin inhibitors].[Practice experience with topical calcineurin inhibitors].Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National Heal A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis.Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis.Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?Position paper on diagnosis and treatment of atopic dermatitis.Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial.

P2860

Q22065280-417A12E5-926F-4477-A3D2-BBD7D257E9E6 Q24186624-8B1FA396-199C-43F1-A319-C3AF1678DB19 Q26852044-320D59D0-67BF-4D5C-B5DA-C5AEAF859817 Q31149849-B9B7F4DC-9130-4DBF-911D-67E2225F76B2 Q33910639-7A401069-0921-4E9A-AF15-485651015641 Q34882570-3BA2C141-6CED-422E-82AE-30991FCDAD42 Q35106685-33D7793E-198B-465B-A674-4A3D24695B62 Q35166799-D344A01C-78E5-4D40-B8BA-2D634AAF45DA Q35906926-A328EAE4-55E7-44AC-9410-27C2B9DFD699 Q35952647-C4127055-D5C7-4941-8EC2-EACB58121B71 Q35961095-D4ACF8D5-0F47-4388-A450-352C4D953408 Q36356956-A0444E67-3377-4AC8-927E-C9BAD0377DA2 Q36466798-C93E1A5B-AE4A-4A75-8783-571F0E9BC6D8 Q36473293-24D18F08-081C-46E4-9A8B-7CF451CF769C Q36940038-DB2EF3ED-8DA9-410C-8718-8CF2B65284FC Q36991444-1C1D391A-B53B-4288-9368-7B5975543027 Q37096190-2C7E62A3-39D0-4645-A3C1-ABB68B43B9BA Q37634335-C56E4F43-07A2-46EC-A2AC-5B9B658CDF1B Q37731539-60879FBB-5D27-43E8-9CD6-46590BA32858 Q37857682-9D18863B-C228-478D-8C61-32A9DAAF4D37 Q37865056-F9838F18-B887-4D0E-8EBA-E1238B633214 Q38933737-C6F4EBD1-2EEF-47C5-9DE2-2BBEF5FE5814 Q39541512-EFA411C7-208C-4C63-824B-8B4D1ABC2479 Q40153230-97217F31-5AF7-49F4-B0CE-1575313BD822 Q42081579-17A6530C-0FF3-4D25-B605-D9EBE0CEE05C Q42263734-873E9B6D-0E75-436B-B7C1-790F18022D4D Q43200436-7D904ADF-2D9D-4C0D-8207-12F453ACD3ED Q44363575-3313DACF-622C-42BA-B3C7-0280E7E02B89 Q44420847-28279D7E-AE58-4214-8B81-2FD0C948D8E9 Q44420855-1F71A0CC-F3E0-440B-B1E7-2396688F7701 Q44420871-BAF68399-FB14-48D3-A423-588C7947E248 Q44513075-FDA48159-4230-423A-9371-2B7F709C4901 Q44628540-111319A7-8285-4C61-80C6-6FFBC8501D60 Q44804913-FD9244D8-6545-49F4-A50D-7F35B4D21933 Q44950241-90B2E7B2-8CCE-4685-AAE8-CAC7F784D6C4 Q45278090-1FE6C335-810F-4D38-92E1-DFAC0C76146D Q45416616-AAD1E51E-7324-41EF-86EF-B499EB317B70 Q46436445-04FD6612-11AE-4C3D-B3CA-A4E8DDB712B0 Q46460423-C3528C77-D173-42F5-A180-F7815268F0C3 Q46565002-33DC6D8A-E22B-4879-9ECE-6F8CD1D39483

P2860

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

http://www.wikidata.org/entity/Q43920215

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@en

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@nl

type

label

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@en

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@nl

prefLabel

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@en

Efficacy and safety of tacroli ...... ildren with atopic dermatitis.

@nl

P1433

Q43920215-C204FE35-276B-4545-AE32-41865F1BAFE9

P1476

Q43920215-CB65EE46-AFF9-4174-9D56-3E62638C50D1

P2093

Q43920215-0872AFBE-361B-4C90-BF3D-DCB462FDC866

Q43920215-1E853CBE-8C9B-4CF9-BAE3-4978879FF074

Q43920215-24673FCD-1B82-4FFF-BD49-E0C83AA2BBA3

Q43920215-3022DFBB-3211-4B90-BEB4-978A2D9705E1

Q43920215-31768EC1-E277-4929-9F46-8E474C750839

Q43920215-487EEB05-0331-49FE-8DFF-2882A1DFAE14

Q43920215-4B0AFCB8-F30A-412A-89A7-4C6429A96EB4

Q43920215-6A27C1AD-F384-404F-B94A-983617053C60

Q43920215-81A86BB8-97F9-4A1D-8106-05D21C6817C1

Q43920215-B3253CB6-167C-453D-B7FA-421129A69FFC

P304

Q43920215-D35BCD28-52AD-4AEC-9A4C-6252E85CEEF5

P31

Q43920215-74A3E3F1-EB4F-4338-A317-4DDA8FF2AF44

P356

Q43920215-30B4F12A-BC51-4148-B01C-56597ECDF859

P407

Q43920215-8EE575E6-6593-4ACE-B3D3-00DA2B033AD6

P433

Q43920215-2995D292-4497-4078-A063-0B61B43942D3

P478

Q43920215-3400795D-4F7B-4223-BE8D-320206F49923

P50

Q43920215-49EAE02C-825B-44FA-83BF-38DAF07A626E

P577

Q43920215-2A31BAA4-5DB1-442B-B3C0-07B0BAE94ABA

P5875

Q43920215-946DAA10-C553-466E-88AC-E0097A8C1124

P698

Q43920215-4320E1D9-EF24-4574-9B01-E538C8A0B4ED

P921

Q43920215-40E034C7-8123-4574-B82E-F68552A5AAEC

P356

MAI.2002.121831

P1433

The Journal of Allergy and Clinical Immunology

P1476

Efficacy and safety of tacroli ...... hildren with atopic dermatitis

@en

P2093

Alain Taïeb

http://www.w3.org/2001/XMLSchema#string

Daniel Sauder

http://www.w3.org/2001/XMLSchema#string

David Gratton

http://www.w3.org/2001/XMLSchema#string

Edwin J M Van Leent

http://www.w3.org/2001/XMLSchema#string

European /Canadian Tacrolimus Ointment Study Group

http://www.w3.org/2001/XMLSchema#string

Frédéric Cambazard

http://www.w3.org/2001/XMLSchema#string

Graham Sharpe

http://www.w3.org/2001/XMLSchema#string

John Harper

http://www.w3.org/2001/XMLSchema#string

Kirsti Kalimo

http://www.w3.org/2001/XMLSchema#string

Malcolm Rustin

http://www.w3.org/2001/XMLSchema#string

P304

539-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MAI.2002.121831

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Catherine H Smith

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11465856

http://www.w3.org/2001/XMLSchema#string

P698

11898004

http://www.w3.org/2001/XMLSchema#string

P921